Skip to main content
. 2019 Aug 31;69(Suppl 2):S49–S57. doi: 10.1093/cid/ciz472

Figure 4.

Figure 4.

Annual number of confirmed Streptococcus pneumoniae meningitis cases by vaccine-associated serotype and African subregion. A, Number of confirmed cases reported by country in South-East Africa: Ethiopia (n = 42), Madagascar (n = 81), Kingdom of Eswatini (formerly Swaziland, n = 6), United Republic of Tanzania (n = 6), Uganda (n = 134), Zambia (n = 94), Zimbabwe (n = 31). Confirmed cases from the following countries were excluded: data unavailable for all surveillance years (Malawi, Mozambique); pneumococcal conjugate vaccine (PCV) not introduced during the surveillance period (Rwanda); at least 2 years of data not available following vaccine introduction (Lesotho); did not report any S. pneumoniae serotyping data (Malawi). B, Number of confirmed cases reported by country in West-Central Africa: Benin (n = 67), Cameroon (n = 57), Ghana (n = 19), Senegal (n = 47), Togo (n = 35). Confirmed cases from the following countries were excluded: data unavailable for all surveillance years (Angola, Central African Republic, Cote d’Ivoire, Sierra Leone); ≤65% PCV coverage for at least 2 consecutive years (Niger, Nigeria); PCV not introduced during the surveillance period (Gambia); did not report any S. pneumoniae serotyping data (Angola, Burkina Faso, Burundi, Central African Republic, Democratic Republic of Congo). Thirteen-valent PCV unique serotypes include 3, 6A, and 19A. Abbreviations: PCV10, 10-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine.